Abstract Objectives: To compare noninvasive estimates of pulmonary artery pressure (PAP) obtained via echocardiography (ECHO) to invasive measurements of PAP obtained during right heart catheterization (RHC) across a range of PAP. To examine the accuracy of estimating right atrial pressure via ECHO (RAP ECHO ) compared to RAP measured by RHC (RAP RHC ), and determine if adding RAP ECHO improves the accuracy of noninvasive PAP estimations. Animals: 14 healthy female beagle dogs. 
Introduction
In veterinary patients, pulmonary hypertension (PH) may be caused by heartworm disease, leftsided heart disease resulting in elevated pulmonary venous pressure, chronic pulmonary diseases, congenital cardiac diseases causing pulmonary overcirculation, thromboembolism, or it may be idiopathic. 1e9 The gold standard test for diagnosis of PH is right heart catheterization (RHC) and direct measurement of pulmonary arterial pressure (PAP). In veterinary patients, procedural costs, associated risks and lack of availability often preclude performing RHC. While echocardiography (ECHO) serves as a preliminary screening tool in human patients, it is often the only diagnostic modality employed in veterinary medicine when confirming Abbreviations ECHO echocardiography EMB embolization dPAP ECHO diastolic pulmonary artery pressure estimated by echocardiography dPAP RHC diastolic pulmonary artery pressure obtained by right heart catheterization mPAP ECHO mean pulmonary artery pressure estimated by echocardiography mPAP RHC mean pulmonary artery pressure obtained by right heart catheterization PAP pulmonary artery pressure PAP ECHO pulmonary artery pressure obtained by echocardiography PAP RHC pulmonary artery pressure obtained by right heart catheterization PH pulmonary hypertension PR pulmonic regurgitation RA right atrium RA size subj subjective right atrial size obtained by echocardiography RAP right atrial pressure RAP ECHO right atrial pressure estimated by subjective right atrial size obtained by echocardiography RAP RHC mean right atrial pressure obtained by right heart catheterization RHC right heart catheterization RV right ventricular sPAP ECHO systolic pulmonary artery pressure estimated by echocardiography sPAP RHC systolic pulmonary artery pressure obtained by right heart catheterization TR tricuspid regurgitation or excluding PH. Chronic moderate to severe PH, regardless of the underlying cause, results in characteristic echocardiographic changes to the right heart, including right ventricular (RV) concentric hypertrophy, RV dilation, changes in tricuspid and pulmonic blood flow and, potentially, RV systolic dysfunction and failure. 1,4,7,8,10e16 Anatomic and functional changes may occur as a result of the interaction of PH and other hemodynamic influences and cannot be used alone to reliably estimate PH severity. Accordingly, an accurate noninvasive method of estimating actual PAP is preferable to diagnose PH in clinical patients.
Recent studies in veterinary patients have used analysis of the tricuspid regurgitation (TR) jet velocity-determined pressure gradient and pulmonic regurgitation (PR) jet velocity-determined pressure gradient, with and without addition of right atrial pressure (RAP) estimates, to estimate systolic PAP (sPAP ECHO ) and diastolic PAP (dPA-P ECHO ), respectively. In recent reports, in humans with PH, the correlation between peak TR pressure gradient as an estimate of sPAP and invasively measured PAP RHC is moderate to poor with a high degree of variability. 11,17e21 Other echocardiographic criteria that have been identified as possible predictors of PH in people and dogs include systolic time intervals, pulse-wave Doppler assessment of pulmonary outflow velocity profile, tricuspid annular plane systolic excursion and tissue Doppler imaging. 1,4,7,15,22e29 These measurements add information to the echocardiographic assessment of PH patients, but the relatively straightforward analysis of PAP through assessment of TR and PR jets remains clinically popular even though the limitations of this type of assessment are widely acknowledged.
The benefits of including RAP obtained by ECHO (RAP ECHO ) in the TR or PR velocity-derived pressure gradient have also been investigated in the human literature, as the modified Bernoulli equation predicts the inclusion of RAP ECHO should increase the accuracy of the sPAP ECHO estimation. Despite this theoretical advantage, the reported effect of including RAP ECHO in the estimate of sPAP ECHO is variable, with several studies failing to consistently show improved correlation when employing this approach. 18, 21, 30, 31 In people, clinical assessment of the jugular veins and an echocardiographic assessment of inferior vena cava collapse are two methods commonly employed in estimating RAP ECHO . In the latter, the patient is instructed to sniff vigorously to decrease intrathoracic pressure and therefore minimize the influence of varying intrathoracic pressure seen during normal respiration. Both this method and jugular assessment are prone to inaccuracy and many investigators suspect this partially explains why adding RAP ECHO does not confer consistent benefit in PAP estimation. 16, 18, 21, 30, 32, 33 In veterinary patients, noninvasively determining RAP ECHO is even more challenging, owing to difficulties in assessing jugular veins and coordinating the respiratory cycle during echocardiography. Identifying a method for accurate estimation of RAP ECHO might increase the accuracy of noninvasively estimating PAP. This possibility has not been thoroughly evaluated in veterinary medicine. Right atrial (RA) size is presumably associated with RAP, and presents a potential tool for estimating RAP ECHO in veterinary patients. Unlike the more spherical left atrium, the RA is ellipsoid in shape and its area and volume are difficult to repeatedly and objectively measure using 2-dimensional imaging methods. As a result, subjective assessment of RA size (RA size subj ) is more commonly reported and used for interpretation. In theory, objective or subjective measures of RA enlargement might provide a method of estimating RAP ECHO , which may then improve noninvasive estimations of PAP.
Even though ECHO estimates of PAP are routinely used in clinical veterinary medicine, 1,2,5e8,28,29 there have been no veterinary studies examining the accuracy of echocardiographically-estimated PAP in dogs. The objectives of this study were thus to compare noninvasive estimates of PAP obtained via ECHO to invasive measurements of PAP obtained by RHC in healthy beagles with experimentallyinduced pulmonary hypertension. Additional study objectives were to examine the accuracy of estimating RAP via ECHO based on subjective and objective assessment of RA size, and to determine if adding estimated RAP ECHO would improve the accuracy of echocardiographically-estimated PAP ECHO . We hypothesized that a correlation between noninvasive estimations and invasive measurements would be present but poor. We also predicted that noninvasive estimation of RAP ECHO would be inaccurate and that including estimated RAP ECHO in PAP estimations would not improve the correlation with invasive measurements.
Materials and methods

Study population and procedural overview
Fourteen intact female beagles were prospectively enrolled in this study between July 2010 and July 2012. The median weight of these animals was 8.5 kg (range 6.8e12 kg), and they were all 1 year of age. All animals were concurrently enrolled in a research project aimed at generating an acute embolization (EMB) model of PH, in which multiple polyvinyl alcohol microbead f injections into the right atrium were performed under general anesthesia. For additional details, see Bellofiore et al., 2013 . 34 After general anesthesia was induced, an initial ECHO was immediately performed. There was a 30 min delay between the initial ECHO and collection of RHC data. Embolization (EMB) was then performed and mean PAP (mPAP RHC ) intermittently measured by RHC until a target mPAP RHC was >30 mmHg (achieved in 7/16 dogs), at which point the next data collection point was reached and RHC and ECHO were again performed. The ECHO measurement following EMB occurred immediately following RHC, once the measurements remained static for a total of 10 min. Accordingly, two data collection points (normotensive at baseline and hypertensive after EMB) were obtained from each anesthetic procedure. For the purposes of this study, RHC data was compared with ECHO data only from the same data collection point (either when PAP pressures were normal at baseline or when they were increased following EMB). This provided comparison of RHC to ECHO across a range of normotensive and hypertensive PAP. Each subject contributed at least two data collection points, one at normal PAP and one at elevated PAP. Some animals underwent multiple EMB procedures on different dates and generated more than two data sets. In summary, the 14 dogs generated 33 pairs of measurements (RHC and ECHO) for analysis.
General anesthesia
General anesthesia was induced with intravenous propofol (10 mg/kg body weight) after intramuscular premedication (midazolam 0.1 mg/kg and hydromorphone 0.1 mg/kg). Following endotracheal intubation, the dogs were maintained during the procedure on isoflurane gas (1e3%) with 100% oxygen and were mechanically ventilated at 11 breaths/minute. Lactated Ringer's solution was infused intravenously at a rate of 10 ml/kg/hr. The femoral and external jugular veins were catheterized for access to the right heart, delivery of microbeads f , contrast injection for angiography and blood collection. Dogs receiving a single EMB were humanely euthanized after conclusion of data collection. Dogs scheduled to receive multiple EMB were either recovered from anesthesia or humanely euthanized at the end of the last procedure. All of the procedures were approved by the Institutional Animal Care and Use Committee of the University of WisconsineMadison.
Echocardiography
Echocardiography g was performed by a boardcertified cardiologist (HBK) on all animals both before and after EMB. Standard right parasternal long axis, right parasternal short axis and left apical views were obtained. 35 Two-dimensional ECHO was used to evaluate chamber size and function, while color flow and spectral Doppler imaging were performed to assess valve regurgitation. The tricuspid valve was interrogated from multiple views, and continuous wave spectral Doppler imaging was used to measure peak TR velocity-determined pressure gradient for estimated sPAP ECHO . Care was taken to align the TR jet as parallel to the plane of the ultrasound interrogation beam as possible. The pulmonic valve was similarly assessed and peak and end PR jet velocity-determined pressure gradients were measured for estimation of mPAP ECHO and dPAP ECHO , respectively. Views of the RA and RV were then optimized from the left-sided apical images for measurement of RA area. RA area was measured at the end of ventricular systole, when the RA was at its maximal size, in three separate ways. First, by tracing the inside border of the RA in this view, with RA area calculated; next by measuring RA height and width and using the standard equation for area of an ellipse [p * (RA h /2) * (RA w /2)]; and finally by using the standard equation for calculating the volume of an ellipse [(4/3) p * (RA h /2) * (RA h /2) * (RA w /2)].
Subjective assessment of RA size (RA size subj ) was reported using the following scoring system: 0 ¼ no enlargement, 1 ¼ mild enlargement, 2 ¼ moderate enlargement and 3 ¼ severe enlargement, using multiple views from the right and left sides. Right atrial pressure (RAP ECHO ) was estimated subjectively using a method previously described by Kittleson, according to the following criteria: RAP ECHO ¼ 5 mmHg if the RA appears normal in size, RAP ECHO ¼ 10 mmHg if the RA appears enlarged but there is no evidence of right-sided heart failure present, and RAP ECHO ¼ 15 mmHg if the RA appears enlarged and there is evidence of right-sided heart failure present. 36 All measurements were made by a board certified cardiologist (HBK). All measurements were performed in triplicate from three f Contour SE Microspheres, Boston Scientific, Natick, MA, USA. g Siemens/Acuson Cypress Plus Ultrasound, ultrasound probe 3e7 MHz, Siemens Medical Solutions, Erlangen D91052, Germany. consecutive cardiac cycles, if possible, and averaged.
Right heart catheterization
All animals underwent RHC using a 7.5 French Swan-Ganz catheter with data collected before and after EMB. A fluid-filled pressure catheter was advanced through a femoral vein to the pulmonary artery. Systolic, diastolic and mean PAP (sPAP RHC , dPAP RHC , mPAP RHC ) were obtained; the catheter was then withdrawn into the RA, and RAP RHC measurements were obtained.
Embolization
A large bore catheter was advanced through an external jugular vein to the right atrium, where polyvinyl alcohol microbeads e were repeatedly injected as previously described. 34 Briefly, 2 mL of 700e900 mm beads were injected first, followed by one or more injections of 2e5 mL of 150e250 mm beads. Mean PAP RHC was intermittently measured and injections were continued until a goal mPAP RHC of >30 mmHg was reached.
Statistics
Right heart catheterization data, ECHO measurements (TR and PR), RA size calculations, RA size subj and RAP ECHO were tested for normality using the D'Agostino and Pearson omnibus test. The majority of the data was non-normally distributed; therefore, non-parametric analyses were used for analysis. ECHO-estimated pressures (sPAP ECHO , dPAP ECHO , mPAP ECHO ) were paired with the corresponding invasive RHC measurements and tested for correlation using a Spearman rho coefficient of correlation. If two indices were determined to be significantly correlated (p < 0.05), linear regression was used to analyze their relationship. Linear regression equations were determined for all comparisons of invasive measurements and noninvasive estimations and assessed for goodness of fit (r 2 ). Right atrial pressure via ECHO was added to the PAP ECHO estimates and these values were again paired with corresponding RHC measurements. Tests for correlation and linear regression were repeated to evaluate whether including RAP ECHO impacted the correlation and/or linear regression. BlandeAltman analyses were also performed to assess the overall accuracy and relatedness of ECHO and RHC.
Receiver operating characteristic (ROC) curves were generated for select data sets to investigate the sensitivity and specificity of ECHO as a means of identifying animals with PH, as defined by a sPAP RHC > 30 mmHg, mPAP RHC > 25 mmHg or dPAP RHC > 10 mmHg. The curves were also used to establish noninvasive cut-off values that can identify PH with maximal possible sensitivity. An additional ROC curve was generated to investigate cutoff values for noninvasive estimates that would predict invasive sPAP RHC > 60 mmHg, since this value represents a degree of PH often considered as a clinical indication for medical treatment in veterinary medicine.
The association between various objective estimates of RA size and actual RAP RHC were analyzed using the Spearman rho correlation test. If two indices were determined to be significantly correlated (p < 0.05), linear regression was then used to analyze their relationship. Animals were assigned 1 of 3 possible RAP ECHO values (5 mmHg, 10 mmHg or 15 mmHg) based on subjective assessment of atrial size. 35 Since no animals were in right-sided congestive heart failure at the time of assessment, animals were allocated to only 2 of the proposed three RAP ECHO groups (5 mmHg and 10 mmHg). The median values for invasive RAP RHC were compared between these groups using a ManneWhitney U test (p < 0.05). For analysis of RA size subj , animals with a score of 2 (n ¼ 3, moderate RA enlargement) and 3 (n ¼ 2, severe RA enlargement) were combined into one group. Median values for RAP RHC were compared among the three RA size subj groups (no enlargement, mild enlargement, moderate/severe enlargement) using the KruskaleWallis test, followed by a posthoc Dunn's multiple comparisons test (p < 0.05).
Results
Pulmonary arterial pressure estimations
There were 33 data collection points available for analysis. In all cases, TR was of sufficient quality for interrogation. Only 21 of 33 data sets had PR of sufficient quantity and quality to permit interrogation. These 21 data sets were used to estimate mPAP ECHO and dPAP ECHO . A summary of invasive and noninvasive values at baseline and post-EMB are presented in Table 1 .
Estimated sPAP ECHO , mPAP ECHO , and dPAP ECHO were all significantly correlated with invasive measurements of sPAP RHC , mPAP RHC and dPAP RHC , respectively. Invasive dPAP RHC was better correlated with end PR velocity-determined pressure gradient than peak PR velocity-determined pressure gradient. When RAP ECHO was included, the correlation improved in all cases. A similar improvement in goodness of fit was observed when RAP ECHO was included in the analysis. Summary statistics are outlined in Table 2 . Selected data sets are displayed in Fig. 1 .
ROC analysis was used to determine optimal noninvasive cut-off values for predicting the presence of PH (sPAP RHC > 30 mmHg and >60 mmHg, mPAP RHC > 25 mmHg or dPAP RHC > 10 mmHg) in these groups. ROC data are summarized in Tables 3a  and b. BlandeAltman analyses were performed for all data sets, and are summarized in Table 4 and Fig. 2 .
Despite a tendency towards underestimation of PAP ECHO , at higher pressures, PAP ECHO overestimation was also present, resulting in 95% limits of agreement for bias that included zero in all cases.
Right atrial pressure and size estimations
Mean RAP values (RAP RHC ) were available in 31 of 33 data sets and RAP was objectively estimated using 3 different methods (Table 2 ) in these dogs. RAP RHC was significant, albeit weakly, correlated with RA size as estimated by the ellipse area method. RAP RHC was not significantly correlated with the RA tracing method or RA ellipse volume method. Median RAP RHC (4 mmHg, range: 0e6 mmHg) for dogs subjectively classified as RAP ECHO of 5 mmHg was mildly but significantly lower than median RAP RHC (5 mmHg, range: 
Discussion
The findings in this study suggest that despite a statistically significant correlation between noninvasive estimates and invasive measurements of PAP, the relationship between the predicted and actual values is highly variable as evidenced by moderate correlation coefficients with wide confidence intervals. The highest correlation coefficients for prediction of PAP RHC were observed when estimates of RAP ECHO were included; however, the actual difference in correlation was negligible suggesting little additional value in including estimates of RAP ECHO in this study. In evaluating the relationship between peak TR gradient and sPAP RHC , noninvasive estimates of PAP appear to have increased variance when PAP is higher. Our results are in agreement with many studies in human patients with PH. Several investigators have reported that using peak TR gradients as surrogates for invasive sPAP RHC measurements is prone to inaccuracy, both for the diagnosis of PH and for classifying its severity, 11,17e21 and another study identified no significant correlation between peak or end-diastolic PR gradients and mPAP RHC or dPAP RHC , respectively. 37 Also similar to what has been reported in human patients, we observed both under and overestimation of actual PAP RHC in this study, with a tendency towards underestimation when using ECHO. 17, 18, 21 Accurate noninvasive estimation requires the presence and identification of a regurgitant jet (TR or PR), proper orientation of the ultrasound beam parallel to the jet, and generation of a flow profile of sufficient quality to permit proper identification of peaks. In the case of PR, identification of an early diastolic peak and end diastolic velocity are both necessary. Improper orientation or incomplete profiles will tend towards underestimation of actual PAP. Additionally, the modified Bernoulli equation applies specifically to blood flowing through a tube with no or negligible frictional losses, traversing across a constant area orifice. Changes in orifice size during the cardiac cycle and the effects of severe regurgitation into large cardiac chambers have been cited as possible causes of underestimation when applying the Bernoulli equation to TR flow. 18, 21 Right ventricular systolic dysfunction, a possible component of severe PH, may also reduce TR velocity, leading to underestimation of true sPAP.
Overestimation of PAP RHC was also noted in our study. In the human literature, inaccuracy in estimating RAP by ECHO is well documented and discussed as the most likely source of overestimation, with underestimation of true RAP resulting in overestimation of PAP ECHO . 16, 18, 30, 32 In our dogs, relatively large overestimations (in some cases > 15 mmHg) remained even after RAP ECHO was added to the peak TR velocity-determined pressure gradient. In those animals where RAP was invasively measured, the median RAP RHC was 4.0 mmHg (range 0e10), and minor discrepancies between actual mean RAP RHC and RAP ECHO would not explain the degree of overestimation observed in several subjects. Alternatively, technical errors such as inaccurate identification of peak regurgitant velocity on the spectral trace or the presence of localized regions of accelerated velocity or vortices within a regurgitant jet are potential sources of this error. Although invasive measurements are considered the gold standard for determining PAP RHC , catheter tip location, catheter obstruction, or signal dampening along the length of the extension set could potentially reduce the measured PAP RHC and predispose to overestimation. Although ECHO and RHC were performed within 30 min of one another in this study, variation in hemodynamic parameters during the course of general anesthesia could also result in apparent under-or overestimation. Animals commonly develop progressive hypothermia and hypotension during the course of anesthesia. Echocardiography was performed prior to RHC in animals at the first data collection point, when PAP was normal, potentially resulting in overestimation of noninvasive estimations among this data. After EMB, which generated elevated PAP, RHC was performed prior to ECHO, potentially resulting in underestimation of noninvasive estimations.
If the modified Bernoulli equation is applicable in the estimation of pressure differential across the tricuspid valve in patients with TR, adding RAP ECHO to the TR velocity-derived pressure differential should provide a more accurate prediction of sPAP RHC . Our findings did not support this theoretical improvement. Reports from the human literature are conflicting, with several studies failing to consistently show improved correlation when employing this approach. 18, 21, 30, 31 In this study, no objective method of assessing RA size was highly correlated to RAP RHC , although there was a significant but weak correlation between RA area, as determined by the ellipse method. Ultimately, RA size subj or RAP ECHO , the two methods employing subjective assessment of RA size, were significantly associated with RAP RHC . The discriminatory ability of these predictors may be limited by the small range of RAP (RHC and subjective) seen in this study. This suggests that RA size may be better evaluated subjectively and that RA size increases with increasing mean RAP RHC . Although difficulties in accurately estimating RAP ECHO have been cited as a potential source of error impacting non-invasively estimated PAP ECHO , the difference between RAP ECHO and actual RAP RHC was low in this study, with a median difference of 1 mmHg (range 0e9 mmHg). This difference likely has minimal impact on noninvasive estimations, particularly in the case of sPAP ECHO , where pressures are much higher than those of the right atrium.
An unexpected finding in our study was that a noninvasively estimated sPAP ECHO > 17.4 mmHg (TR peak velocity > 2.1 m/sec) proved 100% sensitive and 100% specific for identifying animals with an sPAP RHC > 30 mmHg, while a noninvasively estimated sPAP ECHO > 30.6 mmHg (TR velocity > 2.8 m/sec) proved 100% sensitive and 76.76% specific for identifying animals with an invasive sPAP RHC > 60 mmHg (Tables 3a and b) . These are much lower cut-off values than are typically used in veterinary medicine to diagnose PH or estimate severity, and are consistent with the tendency for noninvasive estimations to underestimate actual sPAP RHC . These lower than expected cut-off points may suggest that ECHO assessment leads to underdiagnosis of PH or misclassification of the severity of PH in many canine patients, at least in acute PH situations. The clinical significance of this error, if present in the actual canine population affected by more chronic PH, is unknown.
This study had several limitations. First, measurements were not performed simultaneously, so observed differences could be related to temporal variation in PAP. Significant hourly variation in PAP has been shown in awake human patients with PH, 17 possibly due to variation in total pulmonary resistance associated with severe PH. Although this potential source of error was minimized in our animals by performing measurements within 30 min for the pre-EMB and immediately following RHC measurement stabilization for 10 min for post-EMB, systemic blood pressure was not closely monitored and controlled during the procedure. General anesthetic agents, particularly inhalant gases, are known to reduce systemic and pulmonary pressures. In addition, these animals were receiving 100% inhaled oxygen, which can impact systemic and pulmonary arterial tone and pressure. Although these factors may affect PAP, it is difficult to predict the effect of change of PAP over time on RHC and ECHO at any given time point. Second, measurements were performed on a population of dogs with acutely generated PH, via EMB. This model likely differs from that of chronic PH, where compensatory cardiac remodeling occurs. The impact of chronic versus acute cardiac changes on the predictive value of noninvasive estimates is unknown. Right ventricular systolic failure may play a role in either situation, resulting in a tendency towards underestimation of actual PH based on TR velocity. Right atrial size may not increase with an acute increase in RAP and chronicity may be necessary to increase RA size in the presence of chronic PH. Comparatively, Oyama et al. showed that an acute increase in left atrial pressure, as seen with acute mitral valve insufficiency, was not associated with a significant increase in left atrial size when assessed by ECHO. 38 This limitation of RA size assessment in the acute setting, in addition to the small range of RAP observed after EMB, are clear limitations for the clinical translation of the observed results. Finally, the range of PAP RHC in this acute model of PH was limited, with all PAP <77 mmHg. The predictive value of noninvasive measures at higher pressures and in naturally occurring disease remains unknown.
Conclusions
The study reported here documented a correlation between ECHO estimates of PAP and RAP and invasively measured values. Our results also confirmed a host of previous studies showing inconsistent predictive value of individual noninvasive measurements to predict invasive measurements of PAP and RAP. The results of this study suggest that employing more diagnostic modalities than ECHO alone may add important clinical information to the evaluation of canine patients with PH. Additional studies investigating ECHO measures of RV and pulmonary artery structure and function as indicators of existence and severity of PH are needed.
